Stock of the month
AstraZeneca (AZN) Stock Analysis
The pharma giant scores 86/100 on reward with 251% net income growth. We analyse whether the pipeline justifies the …
86/100
Reward
33/100
Risk
Rolls Royce (RR) Stock Analysis
CEO Erginbilgiç turned a "burning platform" into +94% returns in 12 months. We break down the 131.9% net income CAGR, a …
79/100
Reward
59/100
Risk
NatWest Group (NWG) Stock Analysis
A rare 50% momentum stock or a value trap? We dig into NWG's massive cash pile and how it handles economic pressure.
78/100
Reward
43/100
Risk
Apple (AAPL) Stock Analysis
Trading at 30x P/E; DCF models suggest 15-27% premium to intrinsic value
Read full analysis